$59.38
1.923.34%
At close: -
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Novonesis (Novozymes) B in recent months.
Browse guidance and forecast on all stocks.